SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (14195)11/17/2004 7:21:13 PM
From: Arthur Radley  Respond to of 52153
 
Amazing how one person interprets one way and then the next person sees it in a totally different way...resulting in headlines that often miss the true story.

As for NABI--
[external] Nabi antibody test inconclusive; shares tumble
Wed 6:30pm - at CBS MarketWatch
• InPlay: NABI Biopharma announces positive results from Altastaph Phase II trial results in Neonates
Wed 4:09pm - Briefing.com



To: zeta1961 who wrote (14195)11/17/2004 9:30:29 PM
From: Archie Meeties  Read Replies (1) | Respond to of 52153
 
The staff in that study should be commended for good infection control. That's made a bigger difference in neonatal sepsis than any other intervention.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News